Scholar Rock Holding (SRRK) Total Current Liabilities (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Total Current Liabilities of $59.6 million in Q1 2026, up 7.62% quarter-over-quarter from $55.4 million in Q4 2025, and up 58.73% on a YoY basis from $37.6 million in Q1 2025.

Scholar Rock Holding (SRRK) Total Current Liabilities (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $59.6 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 58.73% year-over-year to $59.6 million; the TTM figure through Mar 2026 stood at $59.6 million (up 58.73% YoY), while the FY2025 annual figure was $55.4 million, up 18.07% from the prior year.
  • Total Current Liabilities was $59.6 million for Q1 2026 at Scholar Rock Holding, up from $55.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $62.0 million in Q3 2025 to a low of $24.3 million in Q2 2023.
  • Historically, Total Current Liabilities has averaged $39.7 million across 5 years, with a median of $37.5 million in 2024.
  • The sharpest annual moves came in 2022 and 2026: Total Current Liabilities slumped 52.29% in 2022, then jumped 58.73% in 2026.
  • A 5-year view of Total Current Liabilities shows it stood at $36.4 million in 2022, then declined by 10.03% to $32.7 million in 2023, then soared by 43.36% to $46.9 million in 2024, then advanced by 18.07% to $55.4 million in 2025, then advanced by 7.62% to $59.6 million in 2026.
  • The last three Total Current Liabilities figures came in at $59.6 million (Q1 2026), $55.4 million (Q4 2025), and $62.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 59.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.64 Mn
Dec 31, 2025 55.42 Mn
Sep 30, 2025 61.97 Mn
Jun 30, 2025 50.44 Mn
Mar 31, 2025 37.57 Mn
Dec 31, 2024 46.94 Mn
Sep 30, 2024 39.37 Mn
Jun 30, 2024 32.99 Mn
Mar 31, 2024 37.51 Mn
Dec 31, 2023 32.74 Mn
Sep 30, 2023 26.73 Mn
Jun 30, 2023 24.27 Mn
Mar 31, 2023 26.21 Mn
Dec 31, 2022 36.39 Mn
Sep 30, 2022 33.74 Mn
Jun 30, 2022 40.16 Mn
Mar 31, 2022 33.37 Mn
Dec 31, 2021 64.30 Mn
Sep 30, 2021 64.60 Mn
Jun 30, 2021 67.02 Mn